Compounds > 16-(2--o-glucopyranosylglucopyranosyloxy)hexadecanoic-acid-1--4---lactone-6--6---diacetate

16-(2--o-glucopyranosylglucopyranosyloxy)hexadecanoic-acid-1--4---lactone-6--6---diacetate and Lung-Neoplasms

16-(2--o-glucopyranosylglucopyranosyloxy)hexadecanoic-acid-1--4---lactone-6--6---diacetate has been researched along with Lung-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for 16-(2--o-glucopyranosylglucopyranosyloxy)hexadecanoic-acid-1--4---lactone-6--6---diacetate and Lung-Neoplasms

ArticleYear
Therapeutic Efficacy of Lactonic Sophorolipids: Nanoceria-Assisted Combination Therapy of NSCLC using HDAC and Hsp90 Inhibitors.
    Nanotheranostics, 2021, Volume: 5, Issue:4

    Topics: A549 Cells; Animals; Antineoplastic Agents; Antioxidants; Carcinoma, Non-Small-Cell Lung; Cerium; CHO Cells; Combined Modality Therapy; Cricetinae; Cricetulus; Glycolipids; Histone Deacetylase Inhibitors; HSP90 Heat-Shock Proteins; Humans; Lung Neoplasms; Triazoles

2021